Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments (2011 - 2026)

Jazz Pharmaceuticals' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $520.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 67.74% year-over-year to $520.0 million; the TTM figure through Mar 2026 stood at $1.6 billion (up 51.69% YoY), while the FY2025 annual figure was $1.4 billion, up 60.95% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $520.0 million, up from $180.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $520.0 million in Q1 2026, with the low at $20.0 million in Q3 2023.
• The 5-year median for Change in Acquisitions & Divestments is $270.0 million (2023), against an average of $254.6 million.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments soared 1675.0% in 2024, then sank 37.93% in 2025.
• Jazz Pharmaceuticals' Change in Acquisitions & Divestments stood at $60.0 million in 2022, then soared by 316.67% to $250.0 million in 2023, then gained by 16.0% to $290.0 million in 2024, then tumbled by 37.93% to $180.0 million in 2025, then surged by 188.89% to $520.0 million in 2026.
• Business Quant data shows JAZZ's Change in Acquisitions & Divestments at $520.0 million in Q1 2026, $180.0 million in Q4 2025, and $400.0 million in Q3 2025.